On June 14, 2021, medical device manufacturer Philips Respironics announced a recall of several models of its CPAP and BI-PAP machines. The reason for the recall was that sound-dampening foam in the affected models was at risk of breaking apart and reaching the airways of patients using these machines. Not only do the particles themselves pose significant health risks if inhaled or ingested, but they also contain volatile organic compounds that can cause other adverse health conditions, including cancer.
Nationwide, people are filing lawsuits against Philips Respironics for becoming sick or injured as a result of using one of its defective devices. The primary grievance against the company is that it allegedly failed to warn consumers of the risks the device posed despite allegedly being aware of the potential for the problem to occur.
The affected CPAP models, used to treat sleep apnea, include the following:
- Dreamstation (First Generation Product Family)
- mniLab Advanced Plus
- Dorma 400
- Dorma 500
- REMStar SE Auto
The affected BI-PAP models, used to treat respiratory failure, include the following:
- Trilogy 100
- Trilogy 200
- Garbin Plus
Symptoms of exposure to foam particles or the toxins they contain include respiratory problems, headaches, irritation, inflammation, and cancer.
Contact Us to Take Legal Action
If you or someone you love is suffering from an illness or injury caused by a Philips Respironics CPAP or BI-PAP machine, our attorneys at Bertram & Graf, L.L.C. can help. We have extensive legal knowledge and experience in the areas of product liability and medical malpractice, which make us well-qualified legal advocates to help those affected by one of these allegedly defective devices.
If you wish to learn more about legal options that may be available to you, we encourage you to schedule a consultation with us as soon as possible. We work on a contingency fee basis, which means you don’t pay unless we win your case.
Request your consultation now by reaching out to us online!